California Stock Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Decheng Capital LLC Invests $28 85 Million in Pacific Biosciences of California, Inc (NASDAQ:PACB)

Decheng Capital LLC Invests $28 85 Million in Pacific Biosciences of California, Inc (NASDAQ:PACB)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesDavidw melinePacific biosciencesDecheng capitalQuest partnersEdmond de rothschild holdingGoldman sachs groupHsbc holdingsDynamic technology lab private ltdUs bancorpCalifornia incJpmorgan chase coFree reportTechnology lab private ltdDirector davidCalifornia stock down

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5 3%

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5 3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesZurcher kantonalbank zurich cantonalbankSanfordc bernsteinPacific biosciencesOene mark vanDavidw melineSecurities exchange commissionAdvisor groupCalifornia company profileChina universal asset management coCalifornia incGoldman sachs groupInterchange capital partnersJpmorgan chase coGet free reportCalifornia stock down

The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $7 00

The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $7 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesOene mark vanPacific biosciencesDavidw melineWolfe researchGoldman sachs groupInvestment managementCalifornia incPricet rowe associates incBlackrock incVanguard group incSecurities exchange commissionCapital international investorsGet free reportCalifornia stock downExchange commission

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5%

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPacific biosciencesDavidw melineChristiano henryVanguard group incCalifornia incCapital international investorsPricet rowe associates incCalifornia company profileBlackrock incWolfe researchInvestment managementSecurities exchange commissionGet free reportCalifornia stock downDirector david

Insider Buying: Pacific Biosciences of California, Inc (NASDAQ:PACB) Director Acquires $176,000 00 in Stock

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) Director David W. Meline purchased 40,000 shares of the stock in a transaction on Wednesday, March 6th. The stock was acquired at an average price of $4.40 per share, with a total value of $176,000.00. Following the acquisition, the director now directly owns 40,000 shares […]

United statesDavidw melinePacific biosciencesComerica bankSecurities exchange commissionKayne anderson rudnick investment managementFairfield bushCalifornia company profileWolfe researchCalifornia incGet free reportDirector davidExchange commissionCalifornia stock downFunds weigh in on pacific biosciencesFinancial advisors